Advertisement

Author: PWeekly

FDA Approves Dotarem, a New MRI Agent

The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older. Dotarem is a...

Read More

AAOS 2013

New research is being presented at AAOS 2013, the Annual Meeting of the American Academy of...

Read More

AAN 2013

New research is being presented at the 65th American Academy of Neurology 2013 Annual Meeting from...

Read More

For latest news and updates
Email-id is invalid